GTHX - G1 Therapeutics drops as breast cancer therapy fails in late-stage trial
2024-06-25 06:59:42 ET
More on G1 Therapeutics
- G1 Therapeutics: Failure Of Breast Cancer Underscores Long-Term Uncertainty
- G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript
- G1 Therapeutics slips after new breast cancer data for lead asset
- G1 Therapeutics jumps amid takeover speculation (update)
- Seeking Alpha’s Quant Rating on G1 Therapeutics